The subject or subject's medical power of attorney has provided written consent to participate in this study.
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Ability to understand and willing to provide informed consent\r\n* If patient unable to understand informed consent, a previously designated durable power of attorney for healthcare or an individual with legal authority may substitute in this capacity\r\n* Assignment of a durable power of attorney for healthcare if not already done
Willing to sign a durable power of attorney.
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Patient or durable power of attorney (DPA) for healthcare must be able to understand and voluntarily sign an Institutional Review Board (IRB) -approved informed consent form
All participants >= 18 years of age must be willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Durable power of attorney form offered (patients >= 18 years of age only)
Willing to sign a durable power of attorney
All patients or their legal guardians (if the patient is < 18 years old) or durable power of attorney (DPA) must sign a document of informed consent indicating their understanding of the investigational nature and the risks of this study; when appropriate, pediatric patients will be included in all discussions in order to obtain verbal assent
Ability of patient or durable power of attorney (DPA) for healthcare to give informed consent
Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).
Patients must have the ability to understand the study, its inherent risks, side effects and potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).
Patients must have the ability to understand the study, its risks, side effects, potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).
Patient or designated individuals with durable medical power of attorney must give written informed consent prior to any study-specific procedures being implemented
Willing to sign a durable power of attorney
Patients must have the ability to understand the study, its inherent risks, side effects and potential benefits and be able to give written informed consent to participate. Patients may not be consented by a durable power of attorney (DPA).
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney
Durable power of attorney form offered (patients >= 18 years of age only)
Willing to sign a durable power of attorney
Willing to sign durable power of attorney
Willing to sign a durable power of attorney
Patient or durable power of attorney (DPA) for healthcare must be able to understand and voluntarily sign an Institutional Review Board (IRB)-approved informed consent form
Willing to sign a durable power of attorney
Willing to sign a durable power of attorney